RREB1 transcription factor splice variants in urologic cancer

American Journal of Pathology

Volumn 179, Issue 1, 2011, Pages 477-486

  Nitz, Matthew D ^a   Harding, Michael A ^b   Smith, Steven C ^b   Thomas, Shibu ^b   Theodorescu, Dan ^b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MESSENGER RNA; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1 ALPHA; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1 BETA; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1 DELTA; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1 EPSILON; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1 GAMMA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA SPLICING; URINARY TRACT CANCER;

ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL PROLIFERATION; CYSTECTOMY; DNA-BINDING PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM INVASIVENESS; PROGNOSIS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 80052452906     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.03.038     Document Type: Article

References (37)

1. P. Traynor, L.M. McGlynn, R. Mukhergee, S.J. Grimsley, J.M. Bartlett, and J. Edwards An increase in N-Ras expression is associated with development of hormone refractory prostate cancer in a subset of patients Dis Markers 24 2008 157 165
2. S. Erlich, P. Tal-Or, R. Liebling, R. Blum, D. Karunagaran, Y. Kloog, and R. Pinkas-Kramarski Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells Biochem Pharmacol 72 2006 427 436
3. M.J. Weber, and D. Gioeli Ras signaling in prostate cancer progression J Cell Biochem 91 2004 13 25
4. J. Min, A. Zaslavsky, G. Fedele, S.K. McLaughlin, E.E. Reczek, T. DE Raedt, I. Guney, D.E. Strochlic, L.E. Macconaill, R. Beroukhim, R.T. Bronson, S. Ryeom, W.C. Hahn, M. Loda, and K. Cichowski An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB Nat Med 16 2010 286 294
5. G. Oxford, and D. Theodorescu The role of Ras superfamily proteins in bladder cancer progression J Urol 170 2003 1987 1993
6. P.L. Nguyen, P.E. Swanson, W. Jaszcz, D.M. Aeppli, G. Zhang, T.P. Singleton, S. Ward, D. Dykoski, J. Harvey, and G.A. Niehans Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder A multivariate survival analysis Am J Clin Pathol 101 1994 166 176
7. D. Theodorescu, I. Cornil, B.J. Fernandez, and R.S. Kerbel Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma Proc Natl Acad Sci USA 87 1990 9047 9051
8. G. Oxford, C.R. Owens, B.J. Titus, T.L. Foreman, M.C. Herlevsen, S.C. Smith, and D. Theodorescu RalA and RalB: antagonistic relatives in cancer cell migration Cancer Res 65 2005 7111 7120
9. J.J. Gildea, M.A. Harding, M.J. Seraj, K.M. Gulding, and D. Theodorescu The role of Ral A in epidermal growth factor receptor-regulated cell motility Cancer Res 62 2002 982 985
10. G. Oxford, S.C. Smith, G. Hampton, and D. Theodorescu Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector Oncogene 26 2007 7143 7152
11. A. Thiagalingam, A. De Bustros, M. Borges, R. Jasti, D. Compton, L. Diamond, M. Mabry, D.W. Ball, S.B. Baylin, and B.D. Nelkin RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas Mol Cell Biol 16 1996 5335 5345
12. W. Xing, and M.R. Sairam Cross talk of two Krupple transcription factors regulates expression of the ovine FSH receptor gene Biochem Biophys Res Commun 295 2002 1096 1101
13. A. Fujimoto-Nishiyama, S. Ishii, S. Matsuda, J. Inoue, and T. Yamamoto A novel zinc finger protein, Finb, is a transcriptional activator and localized in nuclear bodies Gene 195 1997 267 275
14. H. Liu, H.C. Hew, Z.G. Lu, T. Yamaguchi, Y. Miki, and K. Yoshida DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter Biochem J 422 2009 543 551
15. S.K. Ray, J. Nishitani, M.W. Petry, M.Y. Fessing, and A.B. Leiter Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene promoter by the DNA-binding protein Finb/RREB-1 Mol Cell Biol 23 2003 259 271
16. S. Date, Y. Nibu, K. Yanai, J. Hirata, K. Yagami, and A. Fukamizu Finb, a multiple zinc finger protein, represses transcription of the human angiotensinogen gene Int J Mol Med 13 2004 637 642
17. S. Flajollet, I. Poras, E.D. Carosella, and P. Moreau RREB-1 is a transcriptional repressor of HLA-G J Immunol 183 2009 6948 6959
18. B.C. Milon, A. Agyapong, R. Bautista, L.C. Costello, and R.B. Franklin Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells Prostate 70 2010 288 296
19. S. Zhang, X. Qian, C. Redman, V. Bliskovski, E.S. Ramsay, D.R. Lowy, and B.A. Mock p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB Oncogene 22 2003 2285 2295
20. N.K. Mukhopadhyay, B. Cinar, L. Mukhopadhyay, M. Lutchman, A.S. Ferdinand, J. Kim, L.W. Chung, R.M. Adam, S.K. Ray, A.B. Leiter, J.P. Richie, B.C. Liu, and M.R. Freeman The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer Mol Endocrinol 21 2007 2056 2070
21. Y. Shi, J. Sawada, G. Sui, B. Affar el, J.R. Whetstine, F. Lan, H. Ogawa, M.P. Luke, and Y. Nakatani Coordinated histone modifications mediated by a CtBP co-repressor complex Nature 422 2003 735 738
22. M. Melani, K.J. Simpson, J.S. Brugge, and D. Montell Regulation of cell adhesion and collective cell migration by hindsight and its human homolog RREB1 Curr Biol 18 2008 532 537
23. A. Tamori, Y. Yamanishi, S. Kawashima, M. Kanehisa, M. Enomoto, H. Tanaka, S. Kubo, S. Shiomi, and S. Nishiguchi Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA Clin Cancer Res 11 2005 5821 5826
24. A.G. Uren, J. Kool, K. Matentzoglu, J. de Ridder, J. Mattison, M. van Uitert, W. Lagcher, D. Sie, E. Tanger, T. Cox, M. Reinders, T.J. Hubbard, J. Rogers, J. Jonkers, L. Wessels, D.J. Adams, M. van Lohuizen, and A. Berns Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks Cell 133 2008 727 741
25. A.L. Morey, R. Murali, S.W. McCarthy, G.J. Mann, and R.A. Scolyer Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation Pathology 41 2009 383 387
26. P. Gerami, A. Wass, M. Mafee, Y. Fang, M.P. Pulitzer, and K.J. Busam Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi Am J Surg Pathol 33 2009 1783 1788
27. P. Pouryazdanparast, M. Newman, M. Mafee, Z. Haghighat, J. Guitart, and P. Gerami Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization Am J Surg Pathol 33 2009 1396 1400
28. P. Gerami, M. Mafee, T. Lurtsbarapa, J. Guitart, Z. Haghighat, and M. Newman Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes Arch Dermatol 146 2010 273 278
29. K.J. Busam, Y. Fang, S.C. Jhanwar, M.P. Pulitzer, B. Marr, and D.H. Abramson Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization J Cutan Pathol 37 2010 196 203
30. T. Gaiser, H. Kutzner, G. Palmedo, M.D. Siegelin, T. Wiesner, T. Bruckner, W. Hartschuh, A.H. Enk, and M.R. Becker Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up Mod Pathol 23 2010 413 419
31. J.H. Miyake, D.P. Szeto, and W.E. Stumph Analysis of the structure and expression of the chicken gene encoding a homolog of the human RREB-1 transcription factor Gene 202 1997 177 186
32. J.K. Lee, D.M. Havaleshko, H. Cho, J.N. Weinstein, E.P. Kaldjian, J. Karpovich, A. Grimshaw, and D. Theodorescu A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery Proc Natl Acad Sci USA 104 2007 13086 13091
33. E.J. Chapman, C.D. Hurst, E. Pitt, P. Chambers, J.S. Aveyard, and M.A. Knowles Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway Oncogene 25 2006 5037 5045
34. B. Titus, H.F. Frierson Jr, M. Conaway, K. Ching, T. Guise, J. Chirgwin, G. Hampton, and D. Theodorescu Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2 Cancer Res 65 2005 7320 7327
35. S.C. Smith, B. Nicholson, M. Nitz, H.F. Frierson Jr, M. Smolkin, G. Hampton, W. El-Rifai, and D. Theodorescu Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination Am J Pathol 174 2009 371 379
36. M.D. Nitz, M.A. Harding, and D. Theodorescu Invasion and metastasis models for studying RhoGDI2 in bladder cancer Methods Enzymol 439 2008 219 233
37. D.M. Havaleshko, H. Cho, M. Conaway, C.R. Owens, G. Hampton, J.K. Lee, and D. Theodorescu Prediction of drug combination chemosensitivity in human bladder cancer Mol Cancer Ther 6 2007 578 586